Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial
NCT04667481 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2024-02-12
Summary
This clinical trial studies the feasibility of implementing various adaptive training exercise programs to improve cardiorespiratory fitness in patients after receiving breast cancer treatment. Information from this study may help researchers better understand how to implement adaptive training interventions to improve cardiorespiratory fitness in patients after receiving breast cancer treatment.
Conditions
- Breast Cancer
- Invasive Breast Carcinoma
Interventions
- OTHER
-
Aerobic Exercise Intervention
Participate in aerobic exercise intervention
- OTHER
-
Resistance Exercise Intervention
Participate in resistance exercise intervention
- OTHER
-
Exercise Intervention: Digital copies and outline of sessions
Receive digital copy of AE and RE sessions and an outline of sessions
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Kerryn W Reding, PhD, MPH, RN · University of Washington
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-05
- Primary Completion
- 2022-11-10
- Completion
- 2022-11-10
Countries
- United States
Study Locations
More Related Trials
-
High-Intensity Interval Training for Stage I-III Breast Cancer Patients
NCT02454777 ·Status: TERMINATED ·Phase: NA
-
Cardioprotective Effect of Acute Exercise in Breast Cancer Patients
NCT05467111 ·Status: RECRUITING ·Phase: NA
-
Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab
NCT06881940 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
EXercise Influence on Taxane Side Effects (EXIT) Study
NCT02473861 ·Status: COMPLETED ·Phase: NA
-
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
NCT03027063 ·Status: COMPLETED ·Phase: NA
-
Exercise and Tumor Blood Flow in Breast Cancer Patients
NCT04416087 ·Status: UNKNOWN ·Phase: NA
-
Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)
NCT03748550 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
NCT06190600 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
NCT05036252 ·Status: ACTIVE_NOT_RECRUITING
-
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
NCT04361240 ·Status: COMPLETED
-
Survival TRaining for ENhancing Total Health (STRENGTH)
NCT00068458 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
NCT00667251 ·Status: COMPLETED ·Phase: PHASE3
-
Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC
NCT00321048 ·Status: COMPLETED ·Phase: NA
-
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
NCT03959891 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
NCT00872625 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
NCT07023887 ·Status: RECRUITING
-
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
NCT05704829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Taxotere
NCT00206505 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
NCT01275677 ·Status: COMPLETED ·Phase: PHASE3
-
HeartPhone Cancer Survivors Trial 2019
NCT03953326 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer
NCT00206453 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00047099 ·Status: COMPLETED ·Phase: PHASE3
-
Energy Balance and Breast Cancer Aspects-II
NCT02240836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
STOP Heart Disease in Breast Cancer Survivors Trial
NCT02674204 ·Status: TERMINATED ·Phase: PHASE2
-
Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer
NCT00943410 ·Status: COMPLETED ·Phase: PHASE2